QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 17:03 UTC · Public disclosure record

AMNTICKER

Amn Healthcare Services Inc.

INSUFFICIENT DATA stock

Congress has disclosed 4 buys and 1 sell of AMN (Amn Healthcare Services Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

4
Buy
1
Sell
+3
Net
2
Active politicians
Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
17.39
no sector median
how it's calculated
P/E = price ÷ earnings per share
$47.11 ÷ $2.71 = 17.39
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.46
no sector median
how it's calculated
P/B = price ÷ book value per share
$47.11 ÷ $19.14 = 2.46
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
6.26
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($1.8B + $0.4B net debt) ÷ $0.4B = $2.2B ÷ $0.4B = 6.26
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

5 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Greg Gianforte House BUY Joint 2020-11-09 7 days — $15K–$50K 30.7 ↗ filing
Greg Gianforte House BUY Joint 2020-09-02 6 days — $1K–$15K 22.3 ↗ filing
Greg Gianforte House BUY Joint 2020-08-31 8 days — $15K–$50K 56.6 ↗ filing
Greg Gianforte House SELL Joint 2018-12-24 7 days — $100K–$250K 96.7 ↗ filing
Thomas MacArthur House BUY Joint 2018-06-07 24 days — $15K–$50K 90.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in AMN — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

0
Congress trades with insider convergence
0
…with insider divergence
22
Insider open-market trades

Of the congressional trades in AMN, 0 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-06-15 FOLETTA MARK G Director SELL 10b5-1 $52K ↗ EDGAR
2026-06-15 FOLETTA MARK G Director SELL 10b5-1 $62K ↗ EDGAR
2024-11-02 Knudson Jeffrey R C-suite SELL $91K ↗ EDGAR
2024-03-06 Caballero Jorge A. Director BUY $114K ↗ EDGAR
2024-03-04 Fontenot Teri G. Director BUY $100K ↗ EDGAR
2024-02-29 FOLETTA MARK G Director BUY $28K ↗ EDGAR
2024-02-29 HARRIS R JEFFREY Director BUY $150K ↗ EDGAR
2024-02-28 Laughlin Whitney M C-suite BUY $50K ↗ EDGAR
2024-02-28 WHEAT DOUGLAS D Director BUY $149K ↗ EDGAR
2024-02-28 Trent-Adams Sylvia Director BUY $10K ↗ EDGAR
2024-02-28 Knudson Jeffrey R C-suite BUY $401K ↗ EDGAR
2024-02-27 Grace Caroline C-suite BUY $559K ↗ EDGAR
2024-02-27 Grace Caroline C-suite BUY $433K ↗ EDGAR
2023-11-28 Hagan Mark Christopher C-suite SELL $1.1M ↗ EDGAR
2023-06-14 Jones Daphne E Director SELL $87K ↗ EDGAR
2023-06-14 Jones Daphne E Director SELL $23K ↗ EDGAR
2023-04-21 FOLETTA MARK G Director SELL 10b5-1 $129K ↗ EDGAR
2023-04-11 FOLETTA MARK G Director SELL 10b5-1 $421K ↗ EDGAR
2023-04-11 FOLETTA MARK G Director SELL 10b5-1 $89K ↗ EDGAR
2023-01-09 Jackson Denise L C-suite SELL 10b5-1 $443K ↗ EDGAR
2023-01-06 Jackson Denise L C-suite SELL 10b5-1 $110K ↗ EDGAR
2022-02-25 Jackson Denise L C-suite SELL 10b5-1 $493K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-06-15 FOLETTA MARK G Director 10b5-1 SELL $52K
◆ insider 2026-06-15 FOLETTA MARK G Director 10b5-1 SELL $62K
◆ insider 2024-11-02 Knudson Jeffrey R C-suite SELL $91K
◆ insider 2024-03-06 Caballero Jorge A. Director BUY $114K
◆ insider 2024-03-04 Fontenot Teri G. Director BUY $100K
◆ insider 2024-02-29 FOLETTA MARK G Director BUY $28K
◆ insider 2024-02-29 HARRIS R JEFFREY Director BUY $150K
◆ insider 2024-02-28 Laughlin Whitney M C-suite BUY $50K
◆ insider 2024-02-28 WHEAT DOUGLAS D Director BUY $149K
◆ insider 2024-02-28 Trent-Adams Sylvia Director BUY $10K
◆ insider 2024-02-28 Knudson Jeffrey R C-suite BUY $401K
◆ insider 2024-02-27 Grace Caroline C-suite BUY $559K
◆ insider 2024-02-27 Grace Caroline C-suite BUY $433K
◆ insider 2023-11-28 Hagan Mark Christopher C-suite SELL $1.1M
◆ insider 2023-06-14 Jones Daphne E Director SELL $87K
◆ insider 2023-06-14 Jones Daphne E Director SELL $23K
◆ insider 2023-04-21 FOLETTA MARK G Director 10b5-1 SELL $129K
◆ insider 2023-04-11 FOLETTA MARK G Director 10b5-1 SELL $421K
◆ insider 2023-04-11 FOLETTA MARK G Director 10b5-1 SELL $89K
◆ insider 2023-01-09 Jackson Denise L C-suite 10b5-1 SELL $443K
◆ insider 2023-01-06 Jackson Denise L C-suite 10b5-1 SELL $110K
◆ insider 2022-02-25 Jackson Denise L C-suite 10b5-1 SELL $493K
Congress 2020-11-09 Greg Gianforte BUY $15K–$50K
Congress 2020-09-02 Greg Gianforte BUY $1K–$15K

FAQ Common questions

How much has Congress traded AMN?

4 disclosed buys and 1 sells of AMN (Amn Healthcare Services Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade AMN?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.